Palliative Gastrectomy vs. Gastrojejunostomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis

Background: Advanced gastric cancer is the fifth leading cause of cancer-related deaths. Patients with metastatic advanced gastric cancer commonly develop a gastric outlet obstruction that considerably worsens their quality of life. Surgical interventions such as gastrojejunostomy and palliative gas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chunfang Lin, Haibo Fan, Wenjun Chen, Lingzhi Cui
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/c112e18d116a4d7c8e04bd072e0776c6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c112e18d116a4d7c8e04bd072e0776c6
record_format dspace
spelling oai:doaj.org-article:c112e18d116a4d7c8e04bd072e0776c62021-12-01T06:58:25ZPalliative Gastrectomy vs. Gastrojejunostomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis2296-875X10.3389/fsurg.2021.723065https://doaj.org/article/c112e18d116a4d7c8e04bd072e0776c62021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fsurg.2021.723065/fullhttps://doaj.org/toc/2296-875XBackground: Advanced gastric cancer is the fifth leading cause of cancer-related deaths. Patients with metastatic advanced gastric cancer commonly develop a gastric outlet obstruction that considerably worsens their quality of life. Surgical interventions such as gastrojejunostomy and palliative gastrectomy are commonly administered to alleviate this obstruction. However, whether one intervention is better than another at improving morbidity- and mortality-related outcomes is unclear. Thus, in this meta-analysis, we compare outcomes of palliative gastrectomy and gastrojejunostomy (overall hospital stay length, time to oral intake, survival, and complication rates) in patients with metastatic advanced gastric cancer to identify the best procedure.Objective: To compare morbidity and mortality outcomes of palliative gastrectomy and gastrojejunostomy in patients with metastatic advanced gastric cancer.Methods: We followed the PRISMA guidelines to systematically search Web of Science, EMBASE, CENTRAL, Scopus, and MEDLINE for relevant studies. We conducted a random-effects meta-analysis to find differential outcomes between palliative gastrectomy and gastrojejunostomy among variables such as time to oral intake, overall hospital stay length, complication rates, and survival in patients with metastatic advanced gastric cancer.Results: From 963 studies, we found 7 eligible studies with 642 patients (70.3 ± 4.7 years) who had undergone palliative gastrectomy or gastrojejunostomy. Our meta-analysis revealed an insignificant (p > 0.05) differences in terms of overall survival duration (Hedge's g, 1.22), complication risks (odds ratio, 1.35), and time to oral intake (g, 0.62) and hospital stay length (g, 0.12) between patients undergoing gastrojejunostomy and palliative gastrectomy.Conclusion: In this present study we observed no statistically significant differences in terms of morbidity and mortality outcomes after palliative gastrectomy and gastrojejunostomy in patients with metastatic advanced gastric cancer. Therefore, no conclusions can be drawn for the variables evaluated. This study provides a preliminary overview of the risks associated with gastrojejunostomy and palliative gastrectomy to help gastroenterologists manage patients with metastatic advanced-stage gastric cancer.Chunfang LinHaibo FanWenjun ChenLingzhi CuiFrontiers Media S.A.articlegastric cancergastrojejunal bypasspalliative resectioncomplicationsmorbiditymortalitySurgeryRD1-811ENFrontiers in Surgery, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic gastric cancer
gastrojejunal bypass
palliative resection
complications
morbidity
mortality
Surgery
RD1-811
spellingShingle gastric cancer
gastrojejunal bypass
palliative resection
complications
morbidity
mortality
Surgery
RD1-811
Chunfang Lin
Haibo Fan
Wenjun Chen
Lingzhi Cui
Palliative Gastrectomy vs. Gastrojejunostomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
description Background: Advanced gastric cancer is the fifth leading cause of cancer-related deaths. Patients with metastatic advanced gastric cancer commonly develop a gastric outlet obstruction that considerably worsens their quality of life. Surgical interventions such as gastrojejunostomy and palliative gastrectomy are commonly administered to alleviate this obstruction. However, whether one intervention is better than another at improving morbidity- and mortality-related outcomes is unclear. Thus, in this meta-analysis, we compare outcomes of palliative gastrectomy and gastrojejunostomy (overall hospital stay length, time to oral intake, survival, and complication rates) in patients with metastatic advanced gastric cancer to identify the best procedure.Objective: To compare morbidity and mortality outcomes of palliative gastrectomy and gastrojejunostomy in patients with metastatic advanced gastric cancer.Methods: We followed the PRISMA guidelines to systematically search Web of Science, EMBASE, CENTRAL, Scopus, and MEDLINE for relevant studies. We conducted a random-effects meta-analysis to find differential outcomes between palliative gastrectomy and gastrojejunostomy among variables such as time to oral intake, overall hospital stay length, complication rates, and survival in patients with metastatic advanced gastric cancer.Results: From 963 studies, we found 7 eligible studies with 642 patients (70.3 ± 4.7 years) who had undergone palliative gastrectomy or gastrojejunostomy. Our meta-analysis revealed an insignificant (p > 0.05) differences in terms of overall survival duration (Hedge's g, 1.22), complication risks (odds ratio, 1.35), and time to oral intake (g, 0.62) and hospital stay length (g, 0.12) between patients undergoing gastrojejunostomy and palliative gastrectomy.Conclusion: In this present study we observed no statistically significant differences in terms of morbidity and mortality outcomes after palliative gastrectomy and gastrojejunostomy in patients with metastatic advanced gastric cancer. Therefore, no conclusions can be drawn for the variables evaluated. This study provides a preliminary overview of the risks associated with gastrojejunostomy and palliative gastrectomy to help gastroenterologists manage patients with metastatic advanced-stage gastric cancer.
format article
author Chunfang Lin
Haibo Fan
Wenjun Chen
Lingzhi Cui
author_facet Chunfang Lin
Haibo Fan
Wenjun Chen
Lingzhi Cui
author_sort Chunfang Lin
title Palliative Gastrectomy vs. Gastrojejunostomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
title_short Palliative Gastrectomy vs. Gastrojejunostomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
title_full Palliative Gastrectomy vs. Gastrojejunostomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
title_fullStr Palliative Gastrectomy vs. Gastrojejunostomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
title_full_unstemmed Palliative Gastrectomy vs. Gastrojejunostomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
title_sort palliative gastrectomy vs. gastrojejunostomy for advanced gastric cancer: a systematic review and meta-analysis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/c112e18d116a4d7c8e04bd072e0776c6
work_keys_str_mv AT chunfanglin palliativegastrectomyvsgastrojejunostomyforadvancedgastriccancerasystematicreviewandmetaanalysis
AT haibofan palliativegastrectomyvsgastrojejunostomyforadvancedgastriccancerasystematicreviewandmetaanalysis
AT wenjunchen palliativegastrectomyvsgastrojejunostomyforadvancedgastriccancerasystematicreviewandmetaanalysis
AT lingzhicui palliativegastrectomyvsgastrojejunostomyforadvancedgastriccancerasystematicreviewandmetaanalysis
_version_ 1718405438961090560